Magnus Gisslén

InstitutionUniversity of Gothenburg
AddressGothenburg
Sweden
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 2 publications in October 2020 and March 2021 and May 2021 and July 2021 and August 2021
    All Publications
    Bar chart showing 127 publications over 20 distinct years, with a maximum of 13 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tornhammar P, Jernberg T, Bergström G, Blomberg A, Engström G, Engvall J, Fall T, Gisslén M, Janson C, Lind L, Sköld CM, Sundström J, Söderberg S, Zaigham S, Östgren CJ, Andersson DP, Ueda P. Association of cardiometabolic risk factors with hospitalisation or death due to COVID-19: population-based cohort study in Sweden (SCAPIS). BMJ Open. 2021 09 02; 11(9):e051359. PMID: 34475186.
      Citations:    Fields:    Translation:Humans
    2. Edén A, Simrén J, Price RW, Zetterberg H, Gisslén M. Neurochemical biomarkers to study CNS effects of COVID-19: A narrative review and synthesis. J Neurochem. 2021 10; 159(1):61-77. PMID: 34170549.
      Citations: 1     Fields:    Translation:Humans
    3. Beck-Friis J, Leach S, Omerovic E, Zeijlon R, Gisslen M, Yilmaz A. No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not. PLoS One. 2021; 16(8):e0256035. PMID: 34398893.
      Citations:    Fields:    Translation:Humans
    4. Nyberg F, Franzén S, Lindh M, Vanfleteren L, Hammar N, Wettermark B, Sundström J, Santosa A, Björck S, Gisslén M. Swedish Covid-19 Investigation for Future Insights - A Population Epidemiology Approach Using Register Linkage (SCIFI-PEARL). Clin Epidemiol. 2021; 13:649-659. PMID: 34354377.
      Citations: 1     
    5. Kanberg N, Simrén J, Edén A, Andersson LM, Nilsson S, Ashton NJ, Sundvall PD, Nellgård B, Blennow K, Zetterberg H, Gisslén M. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 2021 Aug; 70:103512. PMID: 34333238.
      Citations: 3     Fields:    Translation:HumansCells
    6. Stanne TM, Pedersen A, Gisslén M, Jern C. Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19. Thromb Res. 2021 08; 204:13-15. PMID: 34102452.
      Citations: 2     Fields:    Translation:Humans
    7. Leach S, Harandi AM, Bergström T, Andersson LM, Nilsson S, van der Hoek L, Gisslén M. Comparable endemic coronavirus nucleoprotein-specific antibodies in mild and severe Covid-19 patients. J Med Virol. 2021 09; 93(9):5614-5617. PMID: 33913546.
      Citations:    Fields:    Translation:Humans
    8. Rawshani A, Kjölhede EA, Rawshani A, Sattar N, Eeg-Olofsson K, Adiels M, Ludvigsson J, Lindh M, Gisslén M, Hagberg E, Lappas G, Eliasson B, Rosengren A. Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study. Lancet Reg Health Eur. 2021 May; 4:100105. PMID: 33969336.
      Citations: 7     
    9. Patel H, Ashton NJ, Dobson RJB, Andersson LM, Yilmaz A, Blennow K, Gisslen M, Zetterberg H. Proteomic blood profiling in mild, severe and critical COVID-19 patients. Sci Rep. 2021 03 18; 11(1):6357. PMID: 33737684.
      Citations: 8     Fields:    Translation:Humans
    10. Welén K, Överby AK, Ahlm C, Freyhult E, Robinsson D, Henningsson AJ, Stranne J, Bremell D, Angelin M, Lindquist E, Buckland R, Carlsson CT, Pauksens K, Bill-Axelsson A, Akre O, Ryden C, Wagenius M, Bjartell A, Nilsson AC, Styrke J, Repo J, Balkhed ÅÖ, Niward K, Gisslén M, Josefsson A. COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 16; 22(1):209. PMID: 33726804.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    11. Yilmaz A, Marklund E, Andersson M, Nilsson S, Andersson LM, Lindh M, Gisslén M. Upper Respiratory Tract Levels of Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Duration of Viral RNA Shedding Do Not Differ Between Patients With Mild and Severe/Critical Coronavirus Disease 2019. J Infect Dis. 2021 01 04; 223(1):15-18. PMID: 33020822.
      Citations: 11     Fields:    Translation:Humans
    12. Robertson J, Gostner JM, Nilsson S, Andersson LM, Fuchs D, Gisslen M. Serum neopterin levels in relation to mild and severe COVID-19. BMC Infect Dis. 2020 Dec 10; 20(1):942. PMID: 33302893.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    13. Saguti F, Magnil E, Enache L, Churqui MP, Johansson A, Lumley D, Davidsson F, Dotevall L, Mattsson A, Trybala E, Lagging M, Lindh M, Gisslén M, Brezicka T, Nyström K, Norder H. Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19. Water Res. 2021 Feb 01; 189:116620. PMID: 33212338.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    14. Marklund E, Leach S, Axelsson H, Nyström K, Norder H, Bemark M, Angeletti D, Lundgren A, Nilsson S, Andersson LM, Yilmaz A, Lindh M, Liljeqvist JÅ, Gisslén M. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders. PLoS One. 2020; 15(10):e0241104. PMID: 33085715.
      Citations: 56     Fields:    Translation:HumansCellsPHPublic Health
    15. Edén A, Kanberg N, Gostner J, Fuchs D, Hagberg L, Andersson LM, Lindh M, Price RW, Zetterberg H, Gisslén M. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series. Neurology. 2021 01 12; 96(2):e294-e300. PMID: 33004602.
      Citations: 32     Fields:    Translation:Humans
    16. Kanberg N, Ashton NJ, Andersson LM, Yilmaz A, Lindh M, Nilsson S, Price RW, Blennow K, Zetterberg H, Gisslén M. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020 09 22; 95(12):e1754-e1759. PMID: 32546655.
      Citations: 77     Fields:    Translation:HumansCellsPHPublic Health
    Gisslén's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (174)
    Explore
    _
    Co-Authors (118)
    Explore
    _
    Similar People (60)
    Explore
    _